Mangalam Drugs And Organics Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 30.05 as of 05 May 15:30 . The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of March 2024 .The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2024 . The Market Cap of Mangalam Drugs and Organics Ltd is ₹ 146.65 crore as of March 2024 .The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2024 . The revenue of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ 58.6 crore as compare to the Sep '25 revenue of ₹ 49.57 crore. This represent the growth of 18.22% The revenue of Sanofi Consumer Healthcare India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ -1.32 crore as compare to the Sep '25 ebitda of ₹ -2.81 crore. This represent the decline of -53.02% The ebitda of Sanofi Consumer Healthcare India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 2.68 crore to ₹ -9.84 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2021 to 0 % on December 2024 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 years .

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
The company was promoted by Dhoot family.
The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Mangalam Drugs and Organics Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Mangalam Drugs and Organics Ltd is 47 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr

What are the key factors driving the stock performance of Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 5, 2026, the Mangalam Drugs and Organics Ltd stock price is INR ₹30.05. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6.

How do dividend payouts of Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Mangalam Drugs and Organics Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.